Yoichi Nakayama, Wataru Nagata, Yoichi Takeuchi, Sho Fukui, Yuya Fujita, Yohei Hosokawa, Masanobu Ueno, Kumiko Ono, Shuji Sumitomo, Yuya Tabuchi, Yuichiro Nakanishi, Shuntaro Saito, Hiroko Ikeuchi, Kazutaka Kawamori, Hideaki Sofue, Goro Doi, Runa Minami, Tomoya Hirota, Kaoru Minegishi, Keisuke Maeshima, Ryo Motoyama, Shohei Nakamura, Shotaro Suzuki, Norihiro Nishioka, Takuma Tsuzuki Wada, Akira Onishi, Kenichi Nishimura, Ryu Watanabe, Ryo Yanai, Takashi Kida, Hiroki Nishiwaki, Nobuyuki Yajima, Yuko Kaneko, Eiichi Tanaka, Yutaka Kawahito, Masayoshi Harigai
OBJECTIVES: To update evidence on the efficacy and safety of disease-modifying antirheumatic drugs (DMARDs) and provide information to the taskforce for the 2024 update of the Japan College of Rheumatology (JCR) clinical practice guidelines (CPG) for the management of rheumatoid arthritis (RA). METHODS: We searched various databases for randomised controlled trials on RA published until June 2022, with no language restriction. For each of the 15 clinical questions, 2 independent reviewers screened the articles, evaluated the core outcomes, and performed meta-analyses...
May 30, 2024: Modern Rheumatology